Table 2 Univariate and multivariate analyses of prognostic factors in patients with pancreatic cancer
From: Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma
Variables | Univariable P -value (log-rank test) | Multivariable | |
|---|---|---|---|
HR (95% CI) | P -value | ||
Age at diagnosis (years) | |||
<60 vs. ≥60 | 0.584 | ||
Gender | |||
Male vs. Female | 0.763 | ||
Tumor size (cm) | |||
<2 vs. ≥2 | 0.082 | ||
Histological grades | |||
Well/Moderate vs. Poor | 0.067 | ||
TNM stagea | |||
IA-IB vs. IIA-IIB | 0.013 | 1.23 (1.14-1.52) | 0.026 |
Lymph node metastasis | |||
No vs. Yes | 0.040 | 1.14 (0.97-1.41) | 0.054 |
Vascular invasion | |||
No vs. Yes | 0.017 | 1.27 (1.04-1.49) | 0.042 |
CA19-9 (U/ml) | |||
<27 vs. ≥27 | 0.082 | ||
Bilirubin (μmol/l) | |||
<17.1 vs. ≥17.1 | 0.185 | ||
HSPA2 mRNA expression | |||
Low vs. High | 0.007 | 1.58 (1.11-1.89) | 0.011 |